Pharmacometabolomics identifies candidate predictor metabolites of an L‐carnitine treatment mortality benefit in septic shock
Abstract Sepsis‐induced metabolic dysfunction contributes to organ failure and death. L‐carnitine has shown promise for septic shock, but a recent phase II study of patients with vasopressor‐dependent septic shock demonstrated a non‐significant reduction in mortality. We undertook a pharmacometabolo...
Guardado en:
Autores principales: | Michael A. Puskarich, Theodore S. Jennaro, Christopher E. Gillies, Charles R. Evans, Alla Karnovsky, Cora E. McHugh, Thomas L. Flott, Alan E. Jones, Kathleen A. Stringer, for the RACE Investigators |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wiley
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6ce1ffd631774c4e9df4a19cf077f90d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Pharmacometabolomics for predicting variable busulfan exposure in paediatric haematopoietic stem cell transplantation patients
por: Bora Kim, et al.
Publicado: (2017) -
Effects of therapeutic plasma exchange on the endothelial glycocalyx in septic shock
por: Klaus Stahl, et al.
Publicado: (2021) -
Septic shock: perspective methods of diagnostics and therapy based on immunopathogenesis
por: L. I. Gomanova
Publicado: (2020) -
Meningocoxemic Septic Shock; A Case Report and Review of the Literature
por: Murat Özkale, et al.
Publicado: (2021) -
Telomere shortening during human septic shock: influence of sepsis mediators, role in organ failures, and septic myocardial dysfunction
por: Keyvan Razazi, et al.
Publicado: (2021)